Chinese COVID-19 vaccine candidate appears safe, induces immune response, preliminary study finds

Chinese COVID-19 vaccine candidate appears safe, induces immune response, preliminary study finds Updated : November 18, 2020 11:53 AM IST Data from phase 3 studies will be crucial before any recommendations about the potential uses of CoronaVac could be made. PTI share

Results from an early-phase clinical trial of a Chinese vaccine candidate, CoronaVac, revealed that the formulation appears safe and induces an antibody response in healthy volunteers aged 18 to 59 years.…

This news comes via ChinaPulse.com, which delivers news, data, analysis, and insights on Chinese business, travel, finance, health, military, investment, and technology.

Visit the original:
ChinaPulse.com

Comments are closed.